Brief: Pulse Biosciences Announces Presentation Of Late-Breaking Data From The NPULSE Cardiac Surgical System
10/10/2025 15:44
Oct 10 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ANNOUNCES PRESENTATION OF LATE-BREAKING DATA FROM THE NPULSE™ CARDIAC SURGICAL SYSTEM FIRST-IN-HUMAN FEASIBILITY STUDY AT THE 39TH EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY ANNUAL MEETING PULSE BIOSCIENCES INC - NO MAJOR ADVERSE EVENTS REPORTED IN NPULSE CARDIAC SURGICAL SYSTEM FEASIBILITY STUDY Source text: ID:nBw3l7yRga Further company coverage: PLSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsBrief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants
Chairmen Total Approximately $13.3 Million
Pulse Biosciences records Q1 revenue, but loss widens on higher clinical investment
Brief: Pulse Biosciences Q1 Net Income USD -18.581 Million
Brief: Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System